Nifty
:
25763.35
Sensex
:
83978.49
41.25 (0.16%)
39.78 (0.05%)
Nifty
Sensex
:
:
25763.35
83978.49
41.25 (0.16%)
39.78 (0.05%)

Vivo Bio Tech Ltd.

Miscellaneous

Rating :
53/99

BSE: 511509 | NSE: Not Listed

NSE BSE
32.88
03-Nov-2025
  • Open
  • High
  • Low
  • Previous Close
  •  33.48
  •  33.48
  •  32.8
  •  32.93
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  18581
  •  612973
  •  33.48
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 72.67
  • 8.60
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 125.41
  • N/A
  • 0.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 35.16%
  • 24.89%
  • 32.30%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 7.65%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.83
  • -3.86
  • -4.01

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.43
  • 11.26
  • 5.73

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.59
  • -10.64
  • 4.77

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.79
  • 18.32
  • 16.80

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.75
  • 1.30
  • 0.98

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.35
  • 5.87
  • 5.56

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
12.51
10.13
23.49%
12.29
11.76
4.51%
12.21
12.85
-4.98%
12.04
9.26
30.02%
Expenses
7.02
5.77
21.66%
7.28
6.39
13.93%
6.67
6.47
3.09%
6.44
4.40
46.36%
EBITDA
5.49
4.36
25.92%
5.02
5.37
-6.52%
5.54
6.38
-13.17%
5.59
4.86
15.02%
EBIDTM
43.87%
43.06%
40.81%
45.67%
45.37%
49.63%
46.46%
52.45%
Other Income
0.14
0.01
1,300.00%
0.15
0.01
1,400.00%
0.01
0.03
-66.67%
4.63
0.00
0
Interest
1.50
1.92
-21.88%
1.68
1.52
10.53%
1.84
2.22
-17.12%
2.06
2.09
-1.44%
Depreciation
2.64
2.23
18.39%
2.25
2.43
-7.41%
2.25
2.28
-1.32%
2.29
2.30
-0.43%
PBT
1.48
0.22
572.73%
1.24
1.44
-13.89%
1.46
1.91
-23.56%
5.87
0.46
1,176.09%
Tax
0.14
0.06
133.33%
0.18
0.70
-74.29%
0.64
0.59
8.47%
0.63
0.14
350.00%
PAT
1.34
0.17
688.24%
1.06
0.74
43.24%
0.82
1.32
-37.88%
5.23
0.33
1,484.85%
PATM
10.69%
1.65%
8.65%
6.26%
6.72%
10.28%
43.48%
3.53%
EPS
0.67
0.11
509.09%
0.62
0.49
26.53%
0.51
0.89
-42.70%
3.51
0.22
1,495.45%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
49.05
45.45
52.23
51.39
51.78
55.35
55.83
47.00
34.13
28.58
17.79
Net Sales Growth
11.48%
-12.98%
1.63%
-0.75%
-6.45%
-0.86%
18.79%
37.71%
19.42%
60.65%
 
Cost Of Goods Sold
5.62
3.85
6.77
11.44
7.21
8.56
11.76
9.57
8.14
8.80
3.07
Gross Profit
43.43
41.60
45.46
39.95
44.57
46.79
44.07
37.43
25.98
19.78
14.72
GP Margin
88.54%
91.53%
87.04%
77.74%
86.08%
84.53%
78.94%
79.64%
76.12%
69.21%
82.74%
Total Expenditure
27.41
24.19
30.39
35.30
33.97
42.88
46.32
36.12
26.50
24.88
14.98
Power & Fuel Cost
-
3.93
4.27
3.56
5.78
4.69
2.93
2.87
2.91
2.46
1.68
% Of Sales
-
8.65%
8.18%
6.93%
11.16%
8.47%
5.25%
6.11%
8.53%
8.61%
9.44%
Employee Cost
-
10.68
13.52
9.42
8.57
10.00
9.58
7.66
5.50
4.34
2.94
% Of Sales
-
23.50%
25.89%
18.33%
16.55%
18.07%
17.16%
16.30%
16.11%
15.19%
16.53%
Manufacturing Exp.
-
0.30
0.30
0.21
0.09
2.20
2.14
0.23
0.21
0.09
0.23
% Of Sales
-
0.66%
0.57%
0.41%
0.17%
3.97%
3.83%
0.49%
0.62%
0.31%
1.29%
General & Admin Exp.
-
5.12
5.25
10.45
8.69
9.14
12.37
13.36
9.26
9.09
7.01
% Of Sales
-
11.27%
10.05%
20.33%
16.78%
16.51%
22.16%
28.43%
27.13%
31.81%
39.40%
Selling & Distn. Exp.
-
0.28
0.28
0.12
3.66
0.09
0.81
0.19
0.47
0.08
0.05
% Of Sales
-
0.62%
0.54%
0.23%
7.07%
0.16%
1.45%
0.40%
1.38%
0.28%
0.28%
Miscellaneous Exp.
-
0.02
0.00
0.10
-0.02
8.21
6.73
2.25
0.00
0.01
0.05
% Of Sales
-
0.04%
0%
0.19%
-0.04%
14.83%
12.05%
4.79%
0%
0.03%
0.06%
EBITDA
21.64
21.26
21.84
16.09
17.81
12.47
9.51
10.88
7.63
3.70
2.81
EBITDA Margin
44.12%
46.78%
41.82%
31.31%
34.40%
22.53%
17.03%
23.15%
22.36%
12.95%
15.80%
Other Income
4.93
0.04
0.04
0.10
0.08
0.05
0.01
0.13
0.40
0.89
0.95
Interest
7.08
7.95
7.99
4.27
3.67
3.10
2.64
2.37
1.29
0.47
0.51
Depreciation
9.43
9.29
9.27
7.45
5.59
5.17
5.06
4.64
3.90
3.35
3.05
PBT
10.05
4.06
4.62
4.47
8.62
4.25
1.82
4.01
2.83
0.78
0.19
Tax
1.59
1.53
1.97
2.27
2.94
-0.19
-0.42
0.88
0.33
-0.13
-0.27
Tax Rate
15.82%
37.68%
42.64%
50.78%
34.11%
-4.47%
-23.08%
21.95%
11.66%
-16.67%
-142.11%
PAT
8.45
2.53
2.65
2.20
5.68
4.44
2.25
3.12
2.50
0.91
0.46
PAT before Minority Interest
8.45
2.53
2.65
2.20
5.68
4.44
2.25
3.12
2.50
0.91
0.46
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
17.23%
5.57%
5.07%
4.28%
10.97%
8.02%
4.03%
6.64%
7.32%
3.18%
2.59%
PAT Growth
230.08%
-4.53%
20.45%
-61.27%
27.93%
97.33%
-27.88%
24.80%
174.73%
97.83%
 
EPS
3.82
1.14
1.20
1.00
2.57
2.01
1.02
1.41
1.13
0.41
0.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
54.40
51.87
47.13
42.53
33.02
27.27
19.31
12.58
10.06
9.17
Share Capital
14.90
14.90
14.26
13.42
12.89
12.35
9.85
9.35
9.35
9.35
Total Reserves
39.50
36.97
32.18
27.68
20.14
14.62
7.36
3.22
0.71
-0.18
Non-Current Liabilities
44.82
46.19
52.18
15.16
8.56
9.03
14.77
21.97
15.15
3.94
Secured Loans
39.56
40.33
45.14
12.42
5.46
5.36
6.97
9.17
2.34
2.66
Unsecured Loans
2.23
2.76
4.94
2.23
4.23
3.55
6.93
11.77
11.77
0.00
Long Term Provisions
0.69
0.61
0.55
0.48
0.42
0.36
0.31
0.25
0.20
0.16
Current Liabilities
37.91
24.97
23.18
21.84
20.56
18.78
25.43
16.57
20.45
28.31
Trade Payables
1.06
0.94
2.32
1.39
3.91
3.87
7.98
5.40
8.75
6.85
Other Current Liabilities
8.60
7.72
6.44
4.38
0.00
1.03
3.47
3.92
7.73
13.72
Short Term Borrowings
22.68
11.59
10.92
11.92
14.67
12.77
11.21
6.12
2.81
3.03
Short Term Provisions
5.58
4.72
3.50
4.14
1.97
1.10
2.77
1.13
1.17
4.71
Total Liabilities
137.13
123.03
122.49
79.53
62.14
55.08
59.51
51.12
45.66
41.42
Net Block
80.37
88.87
95.17
52.05
34.99
30.01
27.66
28.57
23.54
19.69
Gross Block
142.06
141.48
138.52
88.01
65.36
55.21
47.81
44.07
35.15
27.94
Accumulated Depreciation
61.69
52.61
43.35
35.97
30.37
25.20
20.14
15.51
11.60
8.25
Non Current Assets
89.59
90.77
96.04
52.37
35.14
30.08
31.61
31.53
23.59
19.76
Capital Work in Progress
9.21
1.90
0.87
0.32
0.15
0.07
3.94
2.96
0.04
0.07
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
47.23
31.79
26.03
27.09
26.92
24.88
27.87
19.57
22.03
21.63
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
8.77
7.97
9.81
13.28
10.58
8.24
7.59
4.56
4.08
4.69
Sundry Debtors
11.80
12.38
12.02
7.29
10.48
8.41
11.78
7.67
3.82
4.31
Cash & Bank
1.39
1.37
1.71
1.17
1.03
0.56
4.15
1.19
11.86
10.56
Other Current Assets
25.27
0.00
0.00
0.00
4.83
7.67
4.35
6.14
2.27
2.07
Short Term Loans & Adv.
25.27
10.06
2.48
5.35
4.26
7.12
4.35
4.27
2.27
2.07
Net Current Assets
9.32
6.82
2.85
5.25
6.36
6.11
2.43
2.99
1.59
-6.68
Total Assets
137.14
123.03
122.49
79.52
62.14
55.07
59.52
51.13
45.66
41.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
15.52
14.83
16.64
14.18
8.61
-0.78
11.11
-5.66
8.81
2.25
PBT
4.06
4.62
4.47
8.62
4.25
1.82
4.01
2.84
0.78
0.19
Adjustment
17.07
16.92
11.44
9.12
8.27
7.70
7.02
5.19
3.82
3.56
Changes in Working Capital
-2.55
-3.37
4.18
2.90
-1.01
-8.08
3.34
-12.07
4.55
-0.96
Cash after chg. in Working capital
18.58
18.17
20.10
20.64
11.52
1.44
14.36
-4.04
9.15
2.79
Interest Paid
-1.52
-1.37
-1.18
-3.53
-3.10
-2.64
-2.37
-1.29
-0.47
-0.51
Tax Paid
-1.53
-1.97
-2.27
-2.94
0.19
0.42
-0.88
-0.33
0.13
-0.03
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-7.95
-4.00
-51.11
-22.82
-10.23
-3.53
-4.72
-11.84
-7.20
-2.04
Net Fixed Assets
-7.89
-3.99
-51.06
-22.82
-7.06
-3.54
-4.71
-11.85
-7.10
-2.04
Net Investments
0.00
0.00
0.00
0.00
-0.01
0.00
0.00
0.00
-0.01
0.12
Others
-0.06
-0.01
-0.05
0.00
-3.16
0.01
-0.01
0.01
-0.09
-0.12
Cash from Financing Activity
-7.56
-11.18
35.02
8.78
2.09
0.72
-3.43
6.83
-0.32
-0.89
Net Cash Inflow / Outflow
0.01
-0.34
0.55
0.14
0.47
-3.59
2.96
-10.67
1.30
-0.68
Opening Cash & Equivalents
1.37
1.71
1.17
1.03
0.56
4.15
1.19
11.86
10.56
11.24
Closing Cash & Equivalent
1.39
1.37
1.71
1.17
1.03
0.56
4.15
1.19
11.86
10.56

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
36.29
34.49
32.27
30.58
25.56
21.75
17.43
13.42
10.72
9.78
ROA
1.94%
2.16%
2.18%
8.02%
7.58%
3.92%
5.64%
5.17%
2.09%
1.14%
ROE
4.79%
5.44%
5.06%
15.36%
14.85%
10.21%
21.01%
22.17%
9.48%
5.25%
ROCE
9.97%
11.06%
9.32%
18.81%
13.85%
9.58%
15.18%
12.39%
5.96%
4.72%
Fixed Asset Turnover
0.32
0.37
0.45
0.68
0.92
1.08
1.02
0.86
0.91
0.66
Receivable days
97.07
85.27
68.60
62.65
62.29
65.98
75.49
61.42
51.89
88.36
Inventory Days
67.24
62.14
81.99
84.09
62.03
51.72
47.16
46.20
55.99
51.24
Payable days
94.94
87.84
59.11
134.26
165.95
65.20
85.31
119.11
152.37
180.24
Cash Conversion Cycle
69.38
59.58
91.49
12.48
-41.63
52.50
37.34
-11.49
-44.49
-40.64
Total Debt/Equity
1.35
1.21
1.47
0.75
0.74
0.81
1.46
2.16
1.69
0.62
Interest Cover
1.51
1.58
2.05
3.35
2.37
1.69
2.69
3.20
2.67
1.37

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Vivo Bio Tech secures pre-clinical testing contract worth Rs 10.75 crore
    20th Aug 2025, 12:13 PM

    The contract is for period of around 2 years

    Read More
  • Vivo Bio Tech - Quarterly Results
    12th Aug 2025, 19:52 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.